Tenon Medical, Inc. (TNON): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.59M
Year ended 2025-12-31
$1.76M
Trailing 12 months to 2026-06-30
+6.0%
3-year compound annual growth
$1.69M2021-12-31: $55.0K2022-12-31: $1.33M2023-12-31: $1.69M2024-12-31: $1.57M2025-12-31: $1.59M$1.59M
2021-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$1.59M+1.3%2026-03-27, From 2025-01-01
2024-12-31$1.57M-7.2%2026-03-27, From 2024-01-01
2023-12-31$1.69M+26.7%2025-03-26, From 2023-01-01
2022-12-31$1.33Mn/m2024-03-29, From 2022-01-01
2021-12-31$55.0Kn/a2023-03-10, From 2021-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Tenon Medical, Inc. (TNON)2025-12-31$1.59M+1.3%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$2.17M+19.9%
IceCure Medical Ltd. (ICCM)2025-12-31$2.15M+17.0%
Nuo Therapeutics, Inc. (AURX)2025-12-31$1.10M+261.8%
Lucid Diagnostics Inc. (LUCD)2025-12-31$6.67M-6.0%
Picard Medical, Inc. (PMI)2025-12-31$5.14M+14.2%
OSR Health, Inc. (OSRH)2025-12-31$2.31M-14.9%
QHSLab, Inc. (USAQ)2025-12-31$880.9K+13.8%
Encision Inc (ECIA)2025-03-31$3.04M-11.8%

Compare TNON, INBS, ICCM, AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗